The Holmes family will be hosting a launch event at 6:30 p.m. on April 25 at the Eldorado Country Club. Attendees can learn ...

Presented a poster highlighting the use of the Company’s Magellan™ drug discovery platform to identify allosteric inhibitors targeting discoidin domain receptor 2 at the 36 th EORTC-NCI-AACR Symposium ...

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

ELIZABETHTOWN, N.C. (WECT) - According to the Parkinson’s Foundation, about 1,000,000 people across the country are living with Parkinson’s disease right now. One of those people is a Bladen County ...

Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease (DKD) ...

Researchers at Indiana University and Wuhan University in China have unveiled a groundbreaking chemical process that could streamline the development of pharmaceutical compounds, chemical building ...

"I wanted to create improved foundation wear or undergarments for individuals with limited mobility, disabilities, or ...

Tetrahydroisoquinolines serve as the foundation for treatments targeting Parkinson's disease, cancer, and cardiovascular disorders.

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...

To mark World Parkinson’s Day this year, Parkinson’s UK is encouraging everyone to show their support and Make It Blue on 11 April and so help raise awareness of Parkinson’s, from lighting up ...

Hall, a 17-year-old girl with a passion for books, is spreading her love of reading through her nonprofit called One Word Reading Initiative, where she gives books to children in need. She was ...